|
|
|
|
| LEADER |
01140nam a2200253 4500 |
| 001 |
c000010353 |
| 003 |
CARM |
| 005 |
00000000000000.0 |
| 008 |
710616s1969 xx 00000 eng d |
| 019 |
1 |
|
|a 5109223
|5 LACONCORD2021
|
| 035 |
|
|
|a (OCoLC)1449339
|5 LACONCORD2021
|
| 040 |
|
|
|a DNLM
|c DNLM
|
| 060 |
0 |
|
|a QV 772
|b N278d 1969
|
| 110 |
2 |
0 |
|a National Research Council (U.S.).
|b Division of Medical Sciences.
|
| 245 |
1 |
0 |
|a Drug efficacy study:
|b final report to the Commissioner of Food and Drugs, Food and Drug Administration.
|
| 260 |
|
|
|a Washington,
|b National Academy of Sciences,
|c 1969.
|
| 300 |
|
|
|a vii, 243 p.
|
| 500 |
|
|
|a This study was sponsored by the Consumer Protection and Environmental Health Service, Food and Drug Administration, FDA Contract 66-197.
|
| 650 |
|
2 |
|a Drugs
|x Standards.
|
| 650 |
|
2 |
|a Drug labeling.
|
| 710 |
2 |
0 |
|a U.S.
|b Consumer Protection and Envionmental Health Service.
|
| 852 |
8 |
|
|b CARM
|h A2:AE03D0
|i D00014
|p 0001644
|f BK
|
| 999 |
f |
f |
|i 88617c0c-088d-5590-86e1-5c9977adf796
|s d97de90a-9929-5aaa-834a-1a8e8b42dbca
|
| 952 |
f |
f |
|p Can circulate
|a CAVAL
|b CAVAL
|c CAVAL
|d CARM 1 Store
|e D00014
|f A2:AE03D0
|h Other scheme
|i book
|m 0001644
|